Our Team

OrphAI Therapeutics boasts a highly accomplished team with executional expertise across all stages of clinical development.

Brigette Roberts, M.D.
Chief Executive Officer, Director
Paul Boni
Chief Financial Officer
Keith Fandrick, Ph.D.
Chief Operating Officer
Joan Edwards
Chief Quality Assurance Officer
Brad Parry, Ph.D.
SVP Research and Computational Biology
Senior Medical Advisors
Eric Rowinsky, MD
Kay Tetzlaff, MD
Board of Directors
David Scheer
Jay Fine, Ph.D.
Jonathan Rothberg, Ph.D.
George Rehm
Murat Gunel, M.D.
Vikram Khanna
Brigette Roberts, M.D.
Scott B Kozak
Chief Business Development Officer
Scientific Advisory Board
Lawrence Melvin, Ph.D.
Tian Xu, Ph.D.